Vanguard National Trust’s ResMed RMD Stock Holding History

Vanguard National Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29K	Hold	149	–	–	﹤0.01%	491
2026 Q1	$33.4K	Buy	+149	New	+$37.1K	﹤0.01%	450

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard National Trust's RMD Position: Q2 2026 in Review

Vanguard National Trust held its ResMed (RMD) position steady in Q2 2026 at 149 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

Vanguard National Trust first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $33.4K in Q1 2026. 879 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Vanguard National Trust held 149 shares of ResMed worth $29K as of Q2 2026.
Vanguard National Trust left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #491 holding.
Vanguard National Trust first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
Vanguard National Trust's ResMed position peaked at $33.4K in Q1 2026.
879 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.